Table 1. Patient characteristics.
| Stage 2 ( n =18) | Stage 3 ( n =13) | Total ( n =31) | |
|---|---|---|---|
| Number of episodes in cohort | 21 | 19 | 40 |
| Primary diagnosis | |||
| Ovarian cancer | 21a | 15b | 36 |
| Gastric cancer | 0 | 1 | 1 |
| Bladder cancer | 0 | 3c | 3c |
| Age | |||
| Mean (range) | 68 (54–84) | 64 (53–77) | 66 (53–84) |
| Albumin | |||
| >30 | 9 | 7 | 16 |
| 25–30 | 5 | 8 | 13 |
| 20–25 | 6 | 0 | 6 |
| <20 | 1 | 0 | 1 |
| Histology of ovarian cancer | |||
| Serous papillary | 16 | 11 | 27 |
| MMMT | 1 | 1 | 2 |
| Adeno NOS | 4 | 3 | 7 |
| Stage | |||
| 2 | 0 | 1 | 1 |
| 3–4 | 21 | 14 | 35 |
| Grade | |||
| 1 | 5 | 5 | 10 |
| 2–3 | 8 | 9 | 17 |
| Unknown | 8 | 1 | 9 |
| Debulked | |||
| Yes | 10 | 10 | 20 |
| No | 11 | 5 | 16 |
| Performance status | |||
| 0–1 (Good) | 7 | 10 | 17 |
| 2 (Intermediate) | 7 | 5 | 12 |
| 3–4 (Poor) | 7 | 0 | 7 |
| Number of previous chemotherapy regimens | |||
| Chemonaive | 3 | 1 | 4 |
| 1 | 4 | 2 | 6 |
| 2 | 9 | 5 | 14 |
| ⩾3 | 5 | 7 | 12 |
| Platinum sensitivity | |||
| Platinum sensitive | 9 | 7 | 16 |
| Platinum resistant | 9 | 8 | 17 |
| Chemonaive | 3 | 0 | 3 |
| Receiving chemotherapy at time of drain | |||
| Yes | 9 | 7 | 16 |
| No | 12d | 8 | 20 |
Abbreviations: MMMT=mixed malignant Mullerian tumour; NOS=adenocarcinoma not otherwise specified.
a
n=18.
b
n=11.
c
n=1.
d
Three were chemonaïve.